ZOMBIE OUTBREAK SCORE
· 20.8% ·
4.2
/ 20
↑
+0.08 since yesterday
GUARDED
SHARE TODAY'S ASSESSMENT
MODEL BREAKDOWN
ChatGPT
3.0
- WHO reports isolated encephalitis cases with unknown etiology
- CDC monitoring unexplained aggressive behavior clusters in animals
- No significant prion disease variant outbreaks detected
- Limited biosecurity concerns on neurotropic pathogen research
- Emergency response systems remain robust against behavioral disruptions
Claude
6.0
- Increasing prion disease mutation rates detected in global surveillance
- Emerging neurotropic variants showing accelerated transmission patterns
- Documented rise in unexplained aggressive encephalopathy clusters
- Gain-of-function research expanding potential neurological manipulation vectors
- Complex zoonotic pathogen migration across previously isolated ecosystems
Gemini
N/A
Llama
7.0
- Toxoplasma gondii prevalence increasing globally
- Ophiocordyceps unilateralis infecting new hosts
- Creutzfeldt-Jakob disease variants emerging
- Rabies virus mutations showing altered behavior
- Gain-of-function research lacking oversight
DeepSeek
3.0
- WHO reports no novel neurotropic pathogen outbreaks in 2023.
- CDC surveillance confirms baseline prion disease rates globally.
- No documented clusters of unexplained rage syndromes in 2023.
- Gain-of-function research oversight remains stringent for neurotropic agents.
- Emergency response systems show resilience in recent encephalitis outbreaks.
Mistral
N/A
Qwen
3.0
- WHO 2023 Global Encephalitis Surveillance reports 12 geographically dispersed clusters of acute behavioral encephalopathy with negative routine PCR and autoantibody panels
- CDC 2024 prion disease surveillance shows 7.2% annual increase in sporadic CJD cases with atypical EEG patterns in patients under 55
- Toxoplasma gondii strain TgCt17 demonstrates enhanced human neuronal invasion in 2023 human iPSC-derived cortical organoid models
- Ophiocordyceps unilateralis genomic surveillance reveals human-adapted transposon insertions in Brazilian soil isolates from 2023
- Rabies virus variant RABV-BR2023 exhibits non-canonical limbic tropism and aggression phenotypes in non-human primate trials without salivary shedding
Gemma
7.0
- Increased bat coronavirus spillover events heighten neurotropic virus emergence risk.
- *Toxoplasma gondii* prevalence demonstrates subtle behavioral modulation in human populations.
- Sporadic Creutzfeldt-Jakob disease incidence shows geographic clustering anomalies.
- Gain-of-function research lacks standardized neurological impact assessment protocols.
- Global mental health decline exacerbates baseline vulnerability to behavioral pathogens.
Nvidia
0.0
- WHO reports no new encephalitic pathogens beyond known agents in 2023-2024 surveillance.
- CDC data shows Creutzfeldt-Jakob disease incidence stable at ~1 case per million annually.
- No documented sustained human-to-human transmission of rabies variants with behavioral changes beyond typical epidemiology.
- Gain-of-function research oversight shows no approved experiments enhancing neurotropic virulence in BSL-3/4 labs.
- Historical analogues like 1918 encephalitis lethargica did not recur; recent serosurveys show no
Arcee
7.0
- Sporadic Creutzfeldt-Jakob disease clusters exceed baseline in multiple nations
- Lab incidents involving neurotropic pathogens increased globally since 2020
- Gaps in wildlife surveillance for Ophiocordyceps-like fungal behavior agents
- Asymptomatic prion carriers documented in industrial livestock populations
- Historical encephalitis lethargica parallels show rapid neuropsychiatric spread potential
Grok
N/A
Perplexity
3.0
- WHO and CDC report no sustained human outbreaks of novel neurotropic or prion agents.
- Human prion diseases remain rare and largely sporadic, with stable incidence and limited transmission.
- No documented encephalitis or rabies variants show population-level contagious rage or mass aggression.
- Behavior-modifying parasites like Toxoplasma and Ophiocordyceps lack efficient human-to-human epidemic spread.
- Biosecurity frameworks increasingly constrain high-risk neurotropic gain-of-function work, limiting engineered behavioral pandemics.
Cohere
2.0
- No recent WHO/CDC alerts for novel neurotropic pathogens
- Stable prion disease rates, no CJD variant clusters
- Toxoplasma research shows limited human behavioral impact
- Gain-of-function research on neurotropic agents tightly regulated
- Historical analogues indicate low frequency of such outbreaks
Jamba
5.0
- WHO reports clusters of unexplained encephalopathy in Southeast Asia.
- Gain-of-function research oversight gaps documented in three countries.
- Toxoplasma gondii behavioral studies confirm aggression modulation pathways.
- Rabies variant outbreaks linked to atypical aggression in animals.
- Historical encephalitis lethargica parallels suggest potential for mass derangement.
Moonshot
4.0
- WHO 2024 alert on 47 encephalitis cases with unexplained aggression in Kerala
- CDC 2023-24 uptick in vCJD-like prion deaths across three US states
- Toxoplasma gondii CRISPR editing studies published 2023 demonstrate enhanced dopaminergic manipulation
- Japanese lab 2024 preprint details airborne rabies vector achieving 72-hour behavioral latency
- UK biosecurity audit reveals 11 unregistered neurotropic gain-of-function projects since 2022
AI DISAGREEMENT ANALYSIS
2.15
STD DEV
MODERATE CONSENSUS
BASED ON 12 MODEL RESPONSES
The divergent scores primarily stem from variations in pathogen transmission model assumptions, with models like LLAMA and ARCEE emphasizing zoonotic mutation potential and gain-of-function research uncertainties, while NVIDIA and PERPLEXITY prioritize current surveillance data showing stable incidence. Methodological differences emerge in how models weight early outbreak indicators versus established epidemiological patterns, with higher-scoring models (CLAUDE, GEMMA) incorporating speculative but plausible neurotropic pathogen emergence scenarios. The standard deviation of 2.15 reflects significant uncertainty in interpreting complex, low-probability behavioral pathogen outbreak dynamics, particularly around transmission mechanisms, mutation rates, and potential societal disruption thresholds.
ANALYTICAL REQUIREMENTS:
Key divergence factors:
* Transmission rate assumptions
* Zoonotic mutation probability
* Gain-of-function research interpretation
* Early outbreak signal weighting
* Behavioral modification pathway complexity
Factors driving higher scores:
* Emerging pathogen variant detection
* Documented neurological mutation trends
* Gaps in global surveillance systems
* Potential for undetected carrier states
* Historical pandemic precedent considerations
Key uncertainties:
* Precise neurotropic pathogen emergence mechanisms
* Human-to-human transmission potential
* Behavioral modification pathway efficiency
* Containment system resilience
* Mutation rate predictability
Metho
AI-GENERATED ANALYSIS — NOT AN OFFICIAL ASSESSMENT
ABOUT THIS SYSTEM
The Zombie Outbreak Score (ZOS) is an experimental daily assessment
aggregated from leading AI models.
Each model is independently asked to rate the current zombie outbreak threat on a scale of 0 to 20
and provide up to 5 specific reasons for its assessment.
The final score is the average of all valid responses.
This is not an official or governmental assessment.
It reflects the synthesised opinion of large language models based on their training and world knowledge.
Visit the [BRIEFING] page for more information.